(Q79961142)
Statements
A randomized phase II pharmacokinetic and pharmacodynamic study of indisulam as second-line therapy in patients with advanced non-small cell lung cancer (English)
Denis C Talbot
Joachim von Pawel
Emma Cattell
S Murray Yule
Claire Johnston
Anthe S Zandvliet
Chris J Norbury
Paul Ellis
Leon Bosquee
Martin Reck
1 March 2007